Device Trial Radar · NCT05291169
Omeza Combination Therapy With Standard of Care to Standard of Care Alone for Chronic Venous Leg Ulcers
Last checked: Nov 20, 2026Latest source record: Jun 6, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
54
Actual
Start
Apr 11, 2022
Primary completion
Nov 30, 2023
Study completion Mar 1, 2024
Sponsor
- Lead sponsor
- Omeza, LLCNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 22, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Randomized, Multicenter, Open Label Study Comparing Omeza Combination Therapy with Standard of Care to Standard of Care alone for Chronic Venous Leg Ulcers over the course of 4 weeks
Conditions
- Venous Leg Ulcer
Interventions
Omeza® OCM™Device
Omeza® OCM™ is a wound care matrix comprised of coldwater fish peptides (device) and cod liver oil (drug). OCM™is supplied in a sterile single use vial.
Primary outcomes
What the sponsor says the trial is designed to measure.
- To evaluate the safety profile of the Omeza Combination Therapy for chronic venous leg ulcersTime frame: 12 weeks
- To evaluate the impact on chronicity of wound healing by Omeza Combination Therapy and Standard of Care (multilayer compression) at week 4 compared to Standard of CareTime frame: 4 weeks
- To evaluate change in ulcer size at week 4 (percent area reduction) compared to baselineTime frame: 4 weeks
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
New Hope Podiatry
Los Angeles, California
Royal Research, Corp
Hollywood, Florida
Three Rivers Wound and Hyperbaric Center
North Port, Florida
4 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.